The nature of the metabolic bone disorder in acromegaly
Riggs, B.L.; Randall, R.V.; Wahner, H.W.; Jowsey, J.; Kelly, P.J.; Singh, M.
Journal of Laboratory and Clinical Medicine 78(5): 822-823
1971
ISSN/ISBN: 0022-2143 PMID: 5128866 Document Number: 41817
Document emailed within 1 workday
Related Documents
Yamada, S.; Inaba, M. 2012: Diabetes mellitus and osteoporosis. Bone metabolic disorder in diabetic nephropathy Clinical Calcium 22(9): 1333-1341Hradec, J.; Marek, J.; Petrásek, J. 1988: The nature of cardiac hypertrophy in acromegaly: an echocardiographic study Cor et Vasa 30(3): 186-199
Landgraf, R.; Landgraf-Leurs, M.M.; von Werder, K.; Scriba, P.C. 1976: Therapy of the diabetic metabolic condition in hyperprolactinemias and acromegaly Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1915-1917
Kajiwara, M.; Yajima, N.; Yamato, H. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Bone histomorphometry for laboratory animals Clinical Calcium 21(4): 534-540
Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336
Pereţianu, D.; Grigorie, D.; Popescu, F.; Zaharescu, J. 1990: Bone scintigraphy in acromegaly. Preliminary report on 10 cases Endocrinologie 28(3-4): 199-205
Berlin, F.S. 2014: Pedophilia and DSM-5: the importance of clearly defining the nature of a Pedophilic Disorder Journal of the American Academy of Psychiatry and the Law 42(4): 404-407
Eby, B.K.; Pesigan, M.; Rodriquez, P.; Kathpalia, S.; Lau, K. 1986: Nature and metabolic consequence of hypophosphaturia in spontaneously hypertensive rats Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(5): S132-S134
Yoshikawa, S. 1986: Etiology and pathology of metabolic bone diseases: Paget's disease of bone and osteosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2437-2442
Mori, S. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Pathophisiology of Microdamage Clinical Calcium 21(4): 559-565
Takami, M.; Shimada, H. 2010: Effects of SERMs on bone health. SERM and metabolic markers of bone Clinical Calcium 20(3): 365-371
Peng, F.; Fu, R.; Liu, H.; Wang, Y.; Ding, K.; Ding, S.; Liu, Z.; Ruan, E.; Qu, W.; Wang, H.; Xing, L.; Wang, X.; Wang, G.; Song, J.; Wu, Y.; Li, L.; Liu, H.; Guan, J.; Shao, Z. 2015: Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease Zhonghua Yi Xue Za Zhi 95(42): 3436-3439
Kirillicheva, G.B.; Tumanian, M.A. 1988: Effect of age-related characteristics of CBA strain mice on the nature of metabolic changes in macrophages exposed to immunomodulators Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 2: 45-47
Takahashi, S. 2013: Bone metabolic markers for evaluation of bone metastases Clinical Calcium 23(3): 391-400
Takeuchi, Y. 2007: Assessment of bone quality with metabolic bone markers Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 214-218
Aquaron, R. 2013: Alkaptonuria: a very rare metabolic disorder Indian Journal of Biochemistry and Biophysics 50(5): 339-344
Smith, U.; Gudbjörnsdottir, S.; Landin, K. 1991: Hypertension as a metabolic disorder--an overview Journal of Internal Medicine. Suppl 735: 1-7
Mikhaĭlichenko, T.E.; Shtoda, L.A.; Cherniĭ, V.V.; Koval', E.N. 1998: A lipid metabolic disorder in diabetics Likars'ka Sprava 4: 85-88
Morimoto, Y. 1986: Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2391-2398
Bombardieri, E.; Setti, L.; Kirienko, M.; Antunovic, L.; Guglielmo, P.; Ciocia, G. 2015: Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(4): 381-399